Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debora Schmitz

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Cancer Research|May 30, 2014
hMOB3 modulates MST1 apoptotic signaling and supports tumor growth in glioblastoma multiformeFengyuan Tang, Lei Zhang, Gongda Xue, et al.
Science Signaling|October 8, 2015
The kinases NDR1/2 act downstream of the Hippo homolog MST1 to mediate both egress of thymocytes from the thymus and lymphocyte motilityFengyuan Tang, Jason Gill, Xenia Ficht, et al.
The Oncologist|September 20, 2022
Inhibition of the Phosphatidylinositol-3 Kinase Pathway Using Bimiralisib in Loss-of-Function NOTCH1-Mutant Head and Neck CancerFaye M Johnson, Filip Janku, Mohamed A Gouda, et al.
Hemasphere|December 13, 2021
A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory LymphomaGraham P Collins, Toby A Eyre, Debora Schmitz-Rohmer, et al.
Cancers|March 25, 2022
Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled TrialSelinde S Wind, Manon A A Jansen, Melanie Rijsbergen, et al.
Cancers|March 11, 2023
Correction: Wind et al. Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled Trial. <i>Cancers</i> 2022, <i>14</i>, 1510Selinde S Wind, Manon A A Jansen, Melanie Rijsbergen, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cancer Research|May 30, 2014
hMOB3 modulates MST1 apoptotic signaling and supports tumor growth in glioblastoma multiformeFengyuan Tang, Lei Zhang, Gongda Xue, et al.
Science Signaling|October 8, 2015
The kinases NDR1/2 act downstream of the Hippo homolog MST1 to mediate both egress of thymocytes from the thymus and lymphocyte motilityFengyuan Tang, Jason Gill, Xenia Ficht, et al.
The Oncologist|September 20, 2022
Inhibition of the Phosphatidylinositol-3 Kinase Pathway Using Bimiralisib in Loss-of-Function NOTCH1-Mutant Head and Neck CancerFaye M Johnson, Filip Janku, Mohamed A Gouda, et al.
Hemasphere|December 13, 2021
A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory LymphomaGraham P Collins, Toby A Eyre, Debora Schmitz-Rohmer, et al.
Cancers|March 25, 2022
Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled TrialSelinde S Wind, Manon A A Jansen, Melanie Rijsbergen, et al.
Cancers|March 11, 2023
Correction: Wind et al. Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled Trial. <i>Cancers</i> 2022, <i>14</i>, 1510Selinde S Wind, Manon A A Jansen, Melanie Rijsbergen, et al.
Pageof 2